LEXICON PHARMACEUTICALS INC's ticker is and the CUSIP is 528872AB0. A total of 11 filers reported holding LEXICON PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,814,000 | -10.8% | 4,500,000 | 0.0% | 0.00% | -50.0% |
Q1 2020 | $2,033,000 | -34.2% | 4,500,000 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $3,090,000 | +7.2% | 4,500,000 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $2,882,000 | -40.3% | 4,500,000 | 0.0% | 0.00% | -33.3% |
Q2 2019 | $4,825,000 | +6.6% | 4,500,000 | 0.0% | 0.00% | 0.0% |
Q1 2019 | $4,525,000 | -9.2% | 4,500,000 | 0.0% | 0.00% | -25.0% |
Q4 2018 | $4,982,000 | -62.9% | 4,500,000 | -50.0% | 0.00% | 0.0% |
Q3 2018 | $13,441,000 | -6.5% | 9,000,000 | 0.0% | 0.00% | 0.0% |
Q2 2018 | $14,382,000 | +146.9% | 9,000,000 | +100.0% | 0.00% | +33.3% |
Q1 2018 | $5,826,000 | – | 4,500,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TFG Asset Management GP Ltd | 17,500,000 | $31,512,000 | 6.26% |
ANGELO GORDON & CO., L.P. | 10,000,000 | $17,913,000 | 1.32% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 12,000,000 | $21,586,000,000 | 0.42% |
WOLVERINE ASSET MANAGEMENT LLC | 8,750,000 | $15,714,000 | 0.20% |
LAZARD ASSET MANAGEMENT LLC | 9,570,000 | $17,190,000 | 0.04% |
Citadel Advisors | 16,800,000 | $30,248,000 | 0.03% |
UBS ASSET MANAGEMENT AMERICAS LLC | 8,000,000 | $14,305,000 | 0.02% |
ClearBridge Investments | 3,000,000 | $5,503,000 | 0.01% |
JPMORGAN CHASE & CO | 1,880,000 | $3,449,000 | 0.00% |